Simultaneous and sequential same-arm measurements in the validation studies of automated blood pressure measuring devices

The oscillometric ambulatory blood pressure recorder Daypress 500 was validated according to the British Hypertension Society protocol. Both sequential and simultaneous measurements were used. Multiple regression analysis demonstrated a significant influence of subject pulse pressure and arm circumference on device-observer systolic pressure differences. Differences between observer consecutive readings were inversely related to heart rate. Device and observer blood pressure readings were closer at simultaneous than at sequential measurements. However, both kinds of measurement led to the same final evaluation (A for diastolic and B for systolic blood pressure), provided that the appropriate grading criteria were applied for each method

Cigarette-smoking effects on circadian rhythm parameters of blood pressure

Ambulatory monitoring of blood pressure (bp) and heart rate in a multicentric Italian study is used to investigate effects of smoking and of a family history of high blood pressure and cardiovascular disease in clinically healthy adults of both genders between 40 and 59 years of age. A higher 24-h rhythm-adjusted mean of systolic blood pressure is found in smokers having a positive family history of high blood pressure. The results of this chronobiologic investigation are reviewed in the context of relations between smoking and cardiovascular morbidity. It appears that the effect of smoking depends in part on interacting factors. The major factor in this context may well be the family history of bp insofar as the results of this study based on a considerable number of observations are considered

A series of novel, potent, and selective histone deacetylase inhibitors

Histone deacetylase (HDAC) inhibitors offer a promising strategy for cancer therapy and the first generation HDAC inhibitors are currently in clinical trials. A structurally novel series of HDAC inhibitors based on the natural cyclic tetrapeptide Apicidin is described. Selected screening of the sample collection looking for L-2-amino-8-oxodecanoic acid (L-Aoda) derivatives identified a small acyclic lead molecule 1 with the unusual ketone zinc binding group. SAR studies around this lead resulted in optimization to potent, low molecular weight, selective, non-hydroxamic acid HDAC inhibitors, equipotent to current clinical candidates